Første forfatter Kreftregisteret
Publisert 2020
Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study
Clin Epidemiol, 12, 193-202
DOI 10.2147/CLEP.S241249, PubMed 32110111
Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study
Clin Epidemiol, 12, 1389-1401
DOI 10.2147/CLEP.S269446, PubMed 33376408
Smoking and Colorectal Cancer Risk, Overall and by Molecular Subtypes: A Meta-Analysis
Am J Gastroenterol, 115 (12), 1940-1949
DOI 10.14309/ajg.0000000000000803, PubMed 32773458
Use of real-world data for HPV vaccine trial follow-up in the Nordic region
Contemp Clin Trials, 92, 105996
DOI 10.1016/j.cct.2020.105996, PubMed 32247041
Definitive radiotherapy for prostate cancer in Norway 2006-2015: Temporal trends, performance and survival
Radiother Oncol, 155, 33-41 (in press)
DOI 10.1016/j.radonc.2020.10.022, PubMed 33096165
Patient age and risk of recurrence of primary melanoma at high risk of spread
Br J Dermatol
DOI 10.1111/bjd.19601, PubMed 33053218
Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening
Br J Cancer, 122 (11), 1715-1723
DOI 10.1038/s41416-020-0790-1, PubMed 32242098
Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway
Cancer Med, 9 (12), 4420-4432
DOI 10.1002/cam4.3060, PubMed 32319230
Cancer incidence in non-immigrants and immigrants in Norway
Acta Oncol, 59 (11), 1275-1283
DOI 10.1080/0284186X.2020.1817549, PubMed 32930622
Screening with 3D mammography – more accurate, but more costly
Tidsskr Nor Laegeforen, 140 (5)
DOI 10.4045/tidsskr.20.0046, PubMed 32238960
Consensus Reads: The More Sets of Eyes Interpreting a Mammogram, the Better for Women
Radiology, 295 (1), 42-43
DOI 10.1148/radiol.2020192746, PubMed 32053060
Misleading and tendentious comments about information in the Norwegian Breast Cancer Screening Programme
Tidsskr Nor Laegeforen, 140 (6)
DOI 10.4045/tidsskr.20.0246, PubMed 32321230
S. Hofvind and colleagues respond
Tidsskr Nor Laegeforen, 140 (8)
DOI 10.4045/tidsskr.20.0379, PubMed 32463197
Response to Zahl
J Natl Cancer Inst, 112 (11), 1175
DOI 10.1093/jnci/djaa130, PubMed 32986835
Ongoing Trials Will Not Determine the Comparative Effectiveness of Colorectal Cancer Screening Tests
Gastroenterology (in press)
DOI 10.1053/j.gastro.2020.02.071, PubMed 32585308
Work Conditions and Practices in Norwegian Fire Departments From 1950 Until Today: A Survey on Factors Potentially Influencing Carcinogen Exposure
Saf Health Work, 11 (4), 509-516
DOI 10.1016/j.shaw.2020.07.004, PubMed 33329918
Association between lifestyle and site-specific advanced colorectal lesions in screening with faecal immunochemical test and sigmoidoscopy
Dig Liver Dis (in press)
DOI 10.1016/j.dld.2020.11.021, PubMed 33309513
Public Awareness and Perceptions of Colorectal Cancer Prevention: a Cross-Sectional Survey
J Cancer Educ
DOI 10.1007/s13187-020-01721-5, PubMed 32112366
Should calculation of chemotherapy dosage for bowel cancer be based on body composition?
Tidsskr Nor Laegeforen, 140 (8)
DOI 10.4045/tidsskr.19.0769, PubMed 32463187
Should calculation of chemotherapy dosage for bowel cancer be based on body composition?
Tidsskr. Nor. Laegeforen., 140 (8), 783-788
Erratum to "HPV16 whole genome minority variants in persistent infections from young Dutch women" [J. Clin. Virol. 119 (2019) 24-30]
J Clin Virol, 124, 104286
DOI 10.1016/j.jcv.2020.104286, PubMed 32057648
Education, income and risk of cancer: results from a Norwegian registry-based study
Acta Oncol, 59 (11), 1300-1307
DOI 10.1080/0284186X.2020.1817548, PubMed 32924698
Self-reported symptoms among participants in a population-based screening program
Breast, 54, 56-61
DOI 10.1016/j.breast.2020.08.015, PubMed 32927237
Factors associated with attendance and attendance patterns in a population-based mammographic screening program
J. Med. Screen., 0969141320932945
Number of prior negative screening outcomes does not influence future risk of breast cancer
Eur J Epidemiol, 35 (6), 549-556
DOI 10.1007/s10654-020-00645-0, PubMed 32430839
La tallene få tale
Tidsskr Nor Laegeforen, 140 (12)
DOI 10.4045/tidsskr.20.0490, PubMed 32900169
Smoking-adjusted risk of kidney cancer by occupation: a population-based cohort study of Nordic men
Acta Oncol, 59 (5), 582-587
DOI 10.1080/0284186X.2020.1714722, PubMed 32009517
Comparing Screening Outcomes for Digital Breast Tomosynthesis and Digital Mammography by Automated Breast Density in a Randomized Controlled Trial: Results from the To-Be Trial
Radiology, 297 (3), 522-531
DOI 10.1148/radiol.2020201150, PubMed 32930649
Can different definitions of date of cancer incidence explain observed international variation in cancer survival? An ICBP SURVMARK-2 study
Cancer Epidemiol, 67, 101759
DOI 10.1016/j.canep.2020.101759, PubMed 32544801
Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016
BMC Cancer, 20 (1), 488
DOI 10.1186/s12885-020-06979-y, PubMed 32473650
Human papillomavirus genotype-specific risks for cervical intraepithelial lesions
Hum Vaccin Immunother
DOI 10.1080/21645515.2020.1814097, PubMed 32990181
The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity
Vaccine, 38 (6), 1345-1351
DOI 10.1016/j.vaccine.2019.12.016, PubMed 31917039
Colorectal cancer screening with repeated fecal immunochemical test versus sigmoidoscopy: baseline results from a randomized trial
Gastroenterology (in press)
DOI 10.1053/j.gastro.2020.11.037, PubMed 33227280
Prevalence of Indoor Tanning Among Teenagers in Norway Before and After Enforcement of Ban for Ages Under 18 Years
Acta Derm Venereol, 100 (8), adv00127
DOI 10.2340/00015555-3482, PubMed 32285136
Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway
J Natl Cancer Inst, 112 (8), 839-846
DOI 10.1093/jnci/djz220, PubMed 31848605
Cohort Profile: The Norwegian Offshore Petroleum Workers (NOPW) Cohort
Int J Epidemiol (in press)
DOI 10.1093/ije/dyaa107, PubMed 32879941
Prediagnostic serum 25-hydroxyvitamin D and melanoma risk
Sci Rep, 10 (1), 20129
DOI 10.1038/s41598-020-77155-2, PubMed 33208828
Drug Use and Cancer Risk: A Drug-Wide Association Study (DWAS) in Norway
Cancer Epidemiol Biomarkers Prev (in press)
DOI 10.1158/1055-9965.EPI-20-1028, PubMed 33144282
Waiting times and treatment following cancer diagnosis: comparison between immigrants and the Norwegian host population
Acta Oncol, 59 (4), 376-383
DOI 10.1080/0284186X.2019.1711167, PubMed 31920119
Chondrosarcoma local recurrence in the Cancer Registry of Norway cohort (1990-2013): Patterns and impact
J Surg Oncol
DOI 10.1002/jso.26308, PubMed 33314135
Risk stratification for central conventional chondrosarcoma of bone: A novel system predicting risk of metastasis and death in the Cancer Registry of Norway cohort
J Surg Oncol, 121 (7), 1115-1125
DOI 10.1002/jso.25883, PubMed 32141094
Socioeconomic inequalities in stage-specific breast cancer incidence: a nationwide registry study of 1.1 million young women in Norway, 2000-2015
Acta Oncol, 59 (11), 1284-1290
DOI 10.1080/0284186X.2020.1753888, PubMed 32319848
Stage-specific survival has improved for young breast cancer patients since 2000: but not equally
Breast Cancer Res Treat, 182 (2), 477-489
DOI 10.1007/s10549-020-05698-z, PubMed 32495000
Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological review
Eur Radiol
DOI 10.1007/s00330-020-07340-4, PubMed 33180162
A 10-year prediagnostic follow-up study shows that serum RNA signals are highly dynamic in lung carcinogenesis
Mol Oncol, 14 (2), 235-247
DOI 10.1002/1878-0261.12620, PubMed 31851411
Kreft i Norge
Tidsskr Nor Laegeforen, 140 (17)
DOI 10.4045/tidsskr.20.0853, PubMed 33231394